$PTIE - New Drug Application with the US FDA has b
Post# of 22756
http://investor.paintrials.com/news-releases/...remoxyr-er
Finally, the moment has come to where we get to experience the slow ramp-up with this stock. The re-approval process takes up to 6 months, since it was already approved for priority review (http://investor.paintrials.com/news-releases/news-release-details/pain-therapeutics-reports-positive-regulatory-meeting-remoxytm)
Take into account the recent news about Purdue Pharma (https://www.usatoday.com/story/news/nation/2018/02/11/oxycontin-maker-cuts-sales-staff-wont-hawk-drug-docs/327251002/) - then does this mean that doctors are going to put more effort into using drugs like remoxy?
What are your thoughts? Are you holding any of this stock today? Do you see a future in Remoxy past the FDA approval process?